#TEK TekCapital PLC investee Co. #BELL Belluscura PLC – Belluscura begins manufacturing in China

LONDON, U.K. AND PLANO, TX, U.S. (3 April 2023). Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen concentrator (“POC”) technology, provides an update on recent progress.   Manufacturing in China Belluscura has commenced manufacturing in China of its X-PLORTM portable oxygen concentrator.   This follows the manufacturing agreement […]

#ORPH Open Orphan – £10.4m contract with existing Big Pharma client

hVIVO to develop new influenza challenge strain to test oral antiviral candidate   Open Orphan plc (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces thathVIVO, a subsidiary of Open Orphan, has signed a £10.4m contract with an existing […]

#POLB Poolbeg Pharma – GMP manufacturing contract signed

Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a clinical stage infectious disease pharmaceutical company with a unique capital light clinical model, announces an update on its lead asset, POLB 001, a small molecule immunomodulator which aims to address a significant unmet need in severe influenza. The Company has signed a contract for GMP […]